FDA Updates

FDA seeks comments on behind-the-counter drugs

FDA advisory committee to discuss OTC cough/ cold products in children under six

Wyeth's new Advil Maximum Strength waiting for FDA approval.

Genetic differences predict anti-inflammatory benefits from nutritional products

NACDS Foundation Chain Pharmacy Industry Profile highlights role of pharmacists

TWC Global issues recall of Axcil and Desirin

Treatments suggested include probiotics coupled with fructooligosaccharides. zinc pyrithione products, glycemic support products, and homeopathic medicines.

Review of new branded drugs, generics, OTCs, home health products, health and beauty aids, etc.

FDA's proposal for new sunscreen regulations address UVA rays as well as other measures consumers may take to protect themselves from UVB rays.

New lung cancer guidelines are released from the American College of Chest Physicians.

Bodee's Zencore Tabs recalled

FDA warns Melanocorp over illegal sale of Melanotan II

New drug approvals for branded drugs, generics, plus OTCs, home health care, health and beauty, etc.

The Consumer Healthcare Products Association is providing educational programs to stop DXM abuse in teens. It also discusses what manufacturers are voluntarily doing to stop teens from purchasing large quantities of cough and cold medicines which contain the ingredients dextromethorphan.

Biopure Corp. has drafted a protocol for patients with life-threatening anemia for whom blood transfusion is not feasible to obtain its investigational product Hemopure (HBOC-201) on a compassionate-use basis.

The FDA has issued an advisory warning for parents never to give cough and cold medicines to children under the age of two unless instructed to do so by a doctor.

Products encompassing newly approved Rx drugs and generics, plus health and beauty care, home health care, and other items.

Organized by HBC category, the never-out list is Hamacher Resource Group's proprietary list of products that pharmacy shelves should never be without. The following is a partial list of never-outs from the weight-control category.

New products in the areas of prescription brand and generic drugs, home health care, health and beauty, etc.

New over the counter items with unique formulations.

DEA has been accused of underestimating the amount of ephedrine needed by the country in Rx and OTC products for 2007.

New drugs, new generics, OTCs, home health care, health & beauty, et al.

This fall there are a host of new products to treat lice and there are many companies that are currently working on new treatments.

Inviro Medical Devices has introduced an integral write-on stripe, Invirostripe, to its complete line of manually retractable InviroSNAP! safety syringes.

Novartis has received final approval for its combination product, Exforge, used to treat hypertension.

Ambrisentan (Letairis) in 5-and 10-mg tablets has been approved by the FDA for the treatment of pulmonary arterial hypertension (PAH).

Rxs, OTCs, Home Health Care, Health and Beauty, and miscellaneous items

Long-acting levocetirizine (Xyzal, UCB/Sanofi-Aventis) has received regulatory approval for the relief of symptoms associated with seasonal and perennial allergic rhinitis and for uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children six years of age and older.

New products for prescription drugs, OTC, home health, health and beauty

New immunosuppressive regimens that combine Certican and low-dose Neoral to preverse renal function following heart transplants and Viagra to lower pulmonary arterial heypertension are coming soon to hospitals.